Invention Grant
US08906853B2 [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
有权
[N-Me-4-羟基亮氨酸] -9-环孢菌素类似物用于治疗和预防丙型肝炎感染
![[N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection](/docs/US/2014-12-09/US08906853B2/abs.jpg.600x600.jpg)
- Patent Title: [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
- Patent Title (中): [N-Me-4-羟基亮氨酸] -9-环孢菌素类似物用于治疗和预防丙型肝炎感染
-
Application No.: US14092171Application Date: 2013-11-27
-
Publication No.: US08906853B2Publication Date: 2014-12-09
- Inventor: Yat Sun Or , In Jong Kim , Jiang Long , Lijuan Jiang , Sheng Sean Liu , Guoqiang Wang
- Applicant: Enanta Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore, Esq.
- Main IPC: A61K38/21
- IPC: A61K38/21 ; A61K31/7056 ; A61K45/06 ; C07K7/64 ; A61K31/713
![[N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection](/abs-image/US/2014/12/09/US08906853B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to novel cyclosporine analogues having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporine analogue compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.
Public/Granted literature
Information query
IPC分类:
